Health
Benefit from delayed 2nd Pfizer jab: study – Corowa Free Press
Pfizer’s COVID-19 vaccine generates antibody responses three-and-a-half times larger in older people when a second dose is delayed to 12 weeks after the first, a British study suggests.The study released on Friday is the first to directly compare immune responses of the Pfizer shot from the three-week dosing interval tested in clinical trials, and the extended 12-week interval that British officials recommend in order to give more vulnerable people at least some protection quickly.
After Britain…
-
Noosa News21 hours agoCommissioner thanks police officer who threw a speed radar at a car
-
Noosa News19 hours agoNo matter what happens in his Origin debut, history beckons for rookie maroon Robert Toia
-
Noosa News20 hours agoDefence investigation finds Taipan pilot’s actions possibly prevented further fatalities in crash
-
General17 hours agoDairy farmers devastated by floods across parts of New South Wales